Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Mark_Payton
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
Early-stage investments
Technology companies Life sciences companies Growth capital Regional businesses |
| gptkbp:foundedYear |
2010
|
| gptkbp:headquartersLocation |
gptkb:Henley-in-Arden,_England
|
| gptkbp:industry |
Venture Capital
Private Equity |
| gptkbp:listedOn |
gptkb:London_Stock_Exchange_AIM
|
| gptkbp:previousName |
gptkb:Mercia_Technologies
|
| gptkbp:stockExchange |
AIM
|
| gptkbp:stockSymbol |
gptkb:MERC
|
| gptkbp:subsidiary |
gptkb:Enterprise_Ventures
gptkb:Mercia_Fund_Management |
| gptkbp:website |
https://www.mercia.co.uk/
|
| gptkbp:bfsParent |
gptkb:Sense_Biodetection
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mercia Asset Management
|